Transgenic sickle mice have vascular inflammation

John D Belcher, Christopher J. Bryant, Julia Nguyen, Paul R. Bowlin, Miroslaw C. Kielbik, John C Bischof, Robert P Hebbel, Gregory M Vercellotti

Research output: Contribution to journalArticle

152 Citations (Scopus)

Abstract

Inflammation may play an essential role in vaso-occlusion in sickle cell disease. Sickle patients have high white counts and elevated levels of serum C-reactive protein (CRP), cytokines, and adhesion molecules. In addition, circulating endothelial cells, leukocytes, and platelets are activated. We examined 4 transgenic mouse models expressing human α- and sickle β-globin genes to determine if they mimic the inflammatory response seen in patients. These mouse models are designated NY-S, Berk-SAntilles, NY-S/SAntilles (NY-S × Berk-SAntilles), and Berk-S. The mean white counts were elevated 1.4- to 2.1-fold (P ≤ .01) in the Berk-SAntilles, NY-S/SAntilles, and Berk-S mice, but not in the NY-S mice compared with controls. Serum amyloid P-component (SAP), an acute-phase response protein with 60% to 70% sequence homology to CRP, was elevated 8.5- to 12.1-fold (P ≤ .001) in transgenic sickle mice. Similarly, serum interleukin-6 (IL-6) was elevated 1.6- to 1.9-fold (P ≤ .05). Western blots, confirming immunohistochemical staining, showed vascular cell adhesion molecule (VCAM), intercellular adhesion molecule (ICAM), and platelet-endothelial cell adhesion molecule (PECAM) were up-regulated 3- to 5-fold (P ≤ .05) in the lungs of sickle mice. Ribonuclease protection assays (RPAs) demonstrated VCAM mRNA also was elevated in sickle mice 1.2- to 1.4-fold (P ≤ .01). Nuclear factor κB (NF-κB), a transcription factor critical for the inflammatory response, was elevated 1.9-fold (P < .006) in NY-S sickle mouse lungs. We conclude that transgenic sickle mice are good models to study vascular inflammation and the potential benefit of anti-inflammatory therapies to prevent vasoocclusion in sickle cell disease.

Original languageEnglish (US)
Pages (from-to)3953-3959
Number of pages7
JournalBlood
Volume101
Issue number10
DOIs
StatePublished - May 15 2003

Fingerprint

Transgenic Mice
Blood Vessels
Vascular Cell Adhesion Molecule-1
Endothelial cells
Cell Adhesion Molecules
Platelets
Inflammation
C-Reactive Protein
Serum Amyloid P-Component
Globins
Sickle Cell Anemia
Ribonucleases
Interleukin-6
Assays
Anti-Inflammatory Agents
Transcription Factors
Blood Platelets
Adhesion
Endothelial Cells
Genes

Cite this

Transgenic sickle mice have vascular inflammation. / Belcher, John D; Bryant, Christopher J.; Nguyen, Julia; Bowlin, Paul R.; Kielbik, Miroslaw C.; Bischof, John C; Hebbel, Robert P; Vercellotti, Gregory M.

In: Blood, Vol. 101, No. 10, 15.05.2003, p. 3953-3959.

Research output: Contribution to journalArticle

Belcher, John D ; Bryant, Christopher J. ; Nguyen, Julia ; Bowlin, Paul R. ; Kielbik, Miroslaw C. ; Bischof, John C ; Hebbel, Robert P ; Vercellotti, Gregory M. / Transgenic sickle mice have vascular inflammation. In: Blood. 2003 ; Vol. 101, No. 10. pp. 3953-3959.
@article{50ee63a4ce68447fb30fb01730f5bda4,
title = "Transgenic sickle mice have vascular inflammation",
abstract = "Inflammation may play an essential role in vaso-occlusion in sickle cell disease. Sickle patients have high white counts and elevated levels of serum C-reactive protein (CRP), cytokines, and adhesion molecules. In addition, circulating endothelial cells, leukocytes, and platelets are activated. We examined 4 transgenic mouse models expressing human α- and sickle β-globin genes to determine if they mimic the inflammatory response seen in patients. These mouse models are designated NY-S, Berk-SAntilles, NY-S/SAntilles (NY-S × Berk-SAntilles), and Berk-S. The mean white counts were elevated 1.4- to 2.1-fold (P ≤ .01) in the Berk-SAntilles, NY-S/SAntilles, and Berk-S mice, but not in the NY-S mice compared with controls. Serum amyloid P-component (SAP), an acute-phase response protein with 60{\%} to 70{\%} sequence homology to CRP, was elevated 8.5- to 12.1-fold (P ≤ .001) in transgenic sickle mice. Similarly, serum interleukin-6 (IL-6) was elevated 1.6- to 1.9-fold (P ≤ .05). Western blots, confirming immunohistochemical staining, showed vascular cell adhesion molecule (VCAM), intercellular adhesion molecule (ICAM), and platelet-endothelial cell adhesion molecule (PECAM) were up-regulated 3- to 5-fold (P ≤ .05) in the lungs of sickle mice. Ribonuclease protection assays (RPAs) demonstrated VCAM mRNA also was elevated in sickle mice 1.2- to 1.4-fold (P ≤ .01). Nuclear factor κB (NF-κB), a transcription factor critical for the inflammatory response, was elevated 1.9-fold (P < .006) in NY-S sickle mouse lungs. We conclude that transgenic sickle mice are good models to study vascular inflammation and the potential benefit of anti-inflammatory therapies to prevent vasoocclusion in sickle cell disease.",
author = "Belcher, {John D} and Bryant, {Christopher J.} and Julia Nguyen and Bowlin, {Paul R.} and Kielbik, {Miroslaw C.} and Bischof, {John C} and Hebbel, {Robert P} and Vercellotti, {Gregory M}",
year = "2003",
month = "5",
day = "15",
doi = "10.1182/blood-2002-10-3313",
language = "English (US)",
volume = "101",
pages = "3953--3959",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "10",

}

TY - JOUR

T1 - Transgenic sickle mice have vascular inflammation

AU - Belcher, John D

AU - Bryant, Christopher J.

AU - Nguyen, Julia

AU - Bowlin, Paul R.

AU - Kielbik, Miroslaw C.

AU - Bischof, John C

AU - Hebbel, Robert P

AU - Vercellotti, Gregory M

PY - 2003/5/15

Y1 - 2003/5/15

N2 - Inflammation may play an essential role in vaso-occlusion in sickle cell disease. Sickle patients have high white counts and elevated levels of serum C-reactive protein (CRP), cytokines, and adhesion molecules. In addition, circulating endothelial cells, leukocytes, and platelets are activated. We examined 4 transgenic mouse models expressing human α- and sickle β-globin genes to determine if they mimic the inflammatory response seen in patients. These mouse models are designated NY-S, Berk-SAntilles, NY-S/SAntilles (NY-S × Berk-SAntilles), and Berk-S. The mean white counts were elevated 1.4- to 2.1-fold (P ≤ .01) in the Berk-SAntilles, NY-S/SAntilles, and Berk-S mice, but not in the NY-S mice compared with controls. Serum amyloid P-component (SAP), an acute-phase response protein with 60% to 70% sequence homology to CRP, was elevated 8.5- to 12.1-fold (P ≤ .001) in transgenic sickle mice. Similarly, serum interleukin-6 (IL-6) was elevated 1.6- to 1.9-fold (P ≤ .05). Western blots, confirming immunohistochemical staining, showed vascular cell adhesion molecule (VCAM), intercellular adhesion molecule (ICAM), and platelet-endothelial cell adhesion molecule (PECAM) were up-regulated 3- to 5-fold (P ≤ .05) in the lungs of sickle mice. Ribonuclease protection assays (RPAs) demonstrated VCAM mRNA also was elevated in sickle mice 1.2- to 1.4-fold (P ≤ .01). Nuclear factor κB (NF-κB), a transcription factor critical for the inflammatory response, was elevated 1.9-fold (P < .006) in NY-S sickle mouse lungs. We conclude that transgenic sickle mice are good models to study vascular inflammation and the potential benefit of anti-inflammatory therapies to prevent vasoocclusion in sickle cell disease.

AB - Inflammation may play an essential role in vaso-occlusion in sickle cell disease. Sickle patients have high white counts and elevated levels of serum C-reactive protein (CRP), cytokines, and adhesion molecules. In addition, circulating endothelial cells, leukocytes, and platelets are activated. We examined 4 transgenic mouse models expressing human α- and sickle β-globin genes to determine if they mimic the inflammatory response seen in patients. These mouse models are designated NY-S, Berk-SAntilles, NY-S/SAntilles (NY-S × Berk-SAntilles), and Berk-S. The mean white counts were elevated 1.4- to 2.1-fold (P ≤ .01) in the Berk-SAntilles, NY-S/SAntilles, and Berk-S mice, but not in the NY-S mice compared with controls. Serum amyloid P-component (SAP), an acute-phase response protein with 60% to 70% sequence homology to CRP, was elevated 8.5- to 12.1-fold (P ≤ .001) in transgenic sickle mice. Similarly, serum interleukin-6 (IL-6) was elevated 1.6- to 1.9-fold (P ≤ .05). Western blots, confirming immunohistochemical staining, showed vascular cell adhesion molecule (VCAM), intercellular adhesion molecule (ICAM), and platelet-endothelial cell adhesion molecule (PECAM) were up-regulated 3- to 5-fold (P ≤ .05) in the lungs of sickle mice. Ribonuclease protection assays (RPAs) demonstrated VCAM mRNA also was elevated in sickle mice 1.2- to 1.4-fold (P ≤ .01). Nuclear factor κB (NF-κB), a transcription factor critical for the inflammatory response, was elevated 1.9-fold (P < .006) in NY-S sickle mouse lungs. We conclude that transgenic sickle mice are good models to study vascular inflammation and the potential benefit of anti-inflammatory therapies to prevent vasoocclusion in sickle cell disease.

UR - http://www.scopus.com/inward/record.url?scp=0037588990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037588990&partnerID=8YFLogxK

U2 - 10.1182/blood-2002-10-3313

DO - 10.1182/blood-2002-10-3313

M3 - Article

C2 - 12543857

AN - SCOPUS:0037588990

VL - 101

SP - 3953

EP - 3959

JO - Blood

JF - Blood

SN - 0006-4971

IS - 10

ER -